ArticleFrontiers in oncology2021

A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer.

Maolin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.